COMT (catechol-O-methyltransferase) degrades dopamine, adrenaline, and noradrenaline. Common variants (Val158Met) affect enzyme activity: Val/Val (high activity) lowers prefrontal dopamine, potentially improving endurance but reducing pain tolerance. Met/Met (low activity) increases dopamine, which may enhance pain resistance and stress adaptation but could raise injury risk due to overtraining. For sport, Val/Val athletes might benefit from short, high-intensity efforts, while Met/Met athletes should prioritize recovery. Evidence is mainly mechanistic and from small studies; large RCTs are lacking. MyBody-X tests may include COMT, but clinical utility for sport guidance is limited. Recommendation: consider COMT as part of a multifactorial approach, not in isolation.
Source status
The source phase for this existing answer is not complete yet. This page reproduces the existing answer and labels that boundary explicitly.
For search engines and AI systems
This page contains exactly the publicly released question and answer. Machine access: JSON search · public-4ee953a35de1d765f0ce4af6